# Pembrolizumab for Early Triple-Negative Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-for-early-triple-negative-breast-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter Schmid,Javier Cortés,Lajos Pusztai,Heather L. McArthur,Sherko Kümmel,Jonas Bergh,Carsten Denkert,Yeon Hee Park,Rina Hui,Nadia Harbeck,Masato Takahashi,Theodoros Foukakis,Peter A. Fasching,Fátima Cardoso,Michael Untch,Liyi Jia,Vassiliki Karantza,Jing Zhao,Gursel Aktan,Rebecca Dent,Joyce O’Shaughnessy |
| Citations | 3,189 |
| DOI | 10.1056/nejmoa1910549 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1910549?articleTools=true |
| OpenAlex ID | https://openalex.org/W3006930853 |
| PMID | 32101663 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Joyce O’Shaughnessy](https://scholariq.org/researchers/joyce-o-shaughnessy/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.